Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas: A meta-analysis

BACKGROUND: The high pretreatment plasma fibrinogen has been widely reported to be a possible biomarker for predicting prognosis in hepatocellular carcinoma (HCC) and pancreatic carcinoma (PC), but persuasive conclusion has not been made yet. Thus, we herein conducted a meta-analysis to comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Rui, Ren, Qian, Bai, Suyang, Wang, Yuping, Zhou, Yongning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023750/
https://www.ncbi.nlm.nih.gov/pubmed/29923974
http://dx.doi.org/10.1097/MD.0000000000010824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023750/
https://www.ncbi.nlm.nih.gov/pubmed/29923974
http://dx.doi.org/10.1097/MD.0000000000010824

Ejemplares similares